More Companies Reducing Size Of Products, Price Stays The SameYou might not notice it right away. But more companies are reducing the size of their products, while the prices stay the same.
CVS Puts Out Generic Competitor To EpiPen At A 6th The PriceCVS is now selling a rival generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated because of its soaring cost.
Drugmakers Set To Gain As Taxpayers Foot New Opioid CostsPharmaceutical industry critics say the new types of drugs the companies are pushing to address the nation's ongoing opioid crisis boost profits while forcing taxpayers to shoulder the costs.
Federal Reserve Chair Yellen Likely To Face Questions About Wells FargoThe nation's second largest bank engaged in practices that allegedly allowed the bank to open millions of accounts without customers' permission.
Mylan CEO Infuriates Lawmakers At Hearing On EpiPen CostsMylan CEO Heather Bresch infuriated lawmakers as she tried to explain steep cost increases of her company's life-saving EpiPens.
Congress Returns From Vacation With Long To-Do List, But Little Chance Of ActionLawmakers will have a little more than four weeks beginning Tuesday before they are scheduled to leave town again before the election.
Feds, Goldman Sachs, Reach $5B Settlement Over Risky MortgagesThe Justice Department announced a $5 billion settlement with Goldman Sachs over the sale of mortgage-backed securities leading up to the 2008 financial crisis.
Texas Oil & Gas Regulators Keep Close Ties To IndustryThe cozy relationship between state oil and gas regulators and the industry they monitor is typified by a revolving door of officials who leave the Texas Railroad Commission to lobby for energy companies, including several who recently departed and made six-figure salaries working the Capitol hallways last year.
Pickens: "We'll Get 67 Votes" To Override Keystone VetoThe U.S. Senate will likely vote next week on the construction of the Keystone XL pipeline, setting up a potential showdown between Republicans and President Barack Obama.
Ex-Enron CEO Skilling Resentenced To 14 YearsFormer Enron Corp. CEO Jeffrey Skilling has been resentenced to 14 years as part of a court-ordered reduction that closes one of the country's most notorious financial scandals.
States' probe of foreclosures could force reforms
Dear Tom Hicks